Is CCRIS 9351 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use CCRIS 9351? Is CCRIS 9351 safe for nursing mother and child? Does CCRIS 9351 extracts into breast milk? Does CCRIS 9351 has any long term or short term side effects on infants? Can CCRIS 9351 influence milk supply or can CCRIS 9351 decrease milk supply in lactating mothers?
CCRIS 9351 lactation summary
- DrLact safety Score for CCRIS 9351 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of CCRIS 9351 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that CCRIS 9351 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using CCRIS 9351 .
- Usage of CCRIS 9351 is in contradiction to breastfeeding hence if it is must to use CCRIS 9351 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About CCRIS 9351 usage in lactation
Steroidal aromatase inhibitor. Using this drug while breastfeeding in not recommended
Answer by DrLact: About CCRIS 9351 usage in lactation
No information is available on the use of CCRIS 9351 during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. The manufacturer recommends that breastfeeding be discontinued during CCRIS 9351 therapy and for 1 month after the last dose.
Alternate Drugs
Cladribine(Dangerous)
Letrozole(Dangerous)
Azelaic Acid(Safe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Exemestane(Dangerous)
Vincristine(Dangerous)
Dactinomycin(Dangerous)
Nilotinib(Unsafe)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Ipilimumab(Unsafe)
Mercaptopurine(Safe)
Cetuximab(Unsafe)
Carboplatin(Dangerous)
Hydroxyurea(Low Risk)
Gemcitabine(Dangerous)
Paclitaxel(Dangerous)
Etoposide(Dangerous)
Fluorouracil(Dangerous)
Doxorubicin(Dangerous)
Alemtuzumab(Low Risk)
Nivolumab(Unsafe)
Cyclophosphamide(Dangerous)
Rituximab(Low Risk)
Vinblastine(Dangerous)
Cisplatin(Unsafe)
Bevacizumab(Low Risk)
Bleomycin(Dangerous)
Docetaxel(Dangerous)
Busulfan(Dangerous)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Trastuzumab(Unsafe)
Dacarbazine(Dangerous)
Imatinib(Unsafe)
Thioguanine(Dangerous)
Exemestane(Dangerous)
Letrozole(Dangerous)